TriMedika Growth Ahead of US Market Entry

Pioneers of innovative medical devices, including a leading non-contact thermometer, TriMedika has delivered 100% year-on-year growth since launching in 2016.

TriMedika has also seen significant uplift in 2020/2021, increasing staff from four to 14. New hires include a five strong dedicated Digital Marketing Team, a Training and Quality Projects Manager, Office Manager, Sales Coordinator and an Engineering Intern.

The recent success is due to a dedicated marketing strategy, improved distributor networks and many countries moving to mandate the use of non-contact thermometers in healthcare.

There is now a greater awareness of the benefits of non-contact in regard to infection control, as a result of the Covid-19 pandemic.

The company now distributes TRITEMP™ in over 21 countries across the globe, listed on major procurement frameworks including NHS Supply Chain.

TriMedika is also in the final stages of R&D for new connected technologies to its portfolio.

Julie Brien COO and co-founder of TriMedika, said: “The development of the next generation product is progressing at pace; this is a connected thermometer which will communicate with hospital electronic patient record systems, to enable seamless data capture and reduce transcription errors.

“Our connected solution will also enable Healthcare Professionals to monitor patient temperature from home, reducing the need to travel to hospital and exposure to potential infection, decreasing stress and contributing to improved bed capacity.”

As TriMedika go from strength to strength, the company has won a number of awards, including The Time Maserati Top 100, Great British Entrepreneur Awards and National Start-up Awards.

CEO Dr Roisin Molloy is finalist for the prestigious upcoming 2021 EY Entrepreneur of the Year award.

As TriMedika continues to grow, they are further expanding their engineering team as they prepare for the next major development; entry to the US and Middle Eastern markets, with plans to extend to 20 staff by the end of 2021.

To find our more about TRITEMP™ - Enquire now